We were interested to learn that physicians are now turning the tables and offering education to the pharmaceutical industry.
For years, the pharmaceutical industry has been involved, either directly or indirectly, with the provision of education to doctors. New guidelines seem certain to change all that. As previously noted in Word on Health, the ACCME, IOM, AMA and others are all seeking to limit the financial relationship between industry and clinicians.
In a joint effort between the University of Chicago Booth School of Business and the University of Chicago Medical Center, a program entitled Understanding the New Breed of Healthcare Decision Makers will launch this May.
The program will focus on the healthcare issues that will dominate the next decade and is designed to provide an insider’s view on how decisions are made by physicians and hospital administrators.
Over the course of five tightly packed days, the course aims to provide sales, marketing, and product management personnel from the pharmaceutical, device and biotech industry with the skills to:
- Improve sales and marketing decision making skills by exploring the doctor-patient relationship and gaining insight into how physicians and surgeons make decisions
- Better anticipate the business impact of current healthcare issues
- Improve marketing strategies by exploring modes of thinking within medical specialties and subspecialties
- Make better resource deployment decisions as the result of improved understanding of hospital supply chain, purchasing, patient flow and operations
- Better anticipate market needs as the result of exposure to key opinion leaders
- Improve product & service positioning strategies by learning how doctors and hospitals define value
- Better understand and empathize with customer s through a unique immersion experience in clinical settings
The cost for the course will be $7,650.
SRxA’s Word on Health would love to hear from you if you’ve signed up.